Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04329039 · ClinicalTrials.gov registry record · Phase 2
Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
A Phase 2 study of Pancreatic Diseases, sponsored by Mayo Clinic.
- Active
- Registry status
- Phase 2
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT04329039: Active Phase 2 study of Pancreatic Diseases, sponsored by Mayo Clinic.
NCT04329039 is a Phase 2 study of Pancreatic Diseases that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 103 participants, below the 1,168-participant average among 5 other Pancreatic Diseases trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04329039, a Phase 2 study of Pancreatic Diseases, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine how the length of antibiotic treatment in addition to octreotide after pancreatic surgery affects the amount of time subjects are hospitalized as well as how many subjects develop pancreatic fistulas.
Conditions Studied
Interventions
- DRUG Somatostatin analog
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2020-11-17 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
What the registry record for NCT04329039 still lists
NCT04329039 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,168-participant average among 5 other Pancreatic Diseases trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Pancreatic Diseases appearing as the primary indexed condition, and to 1 intervention - of which Somatostatin analog is the first listed.
NCT04329039 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04329039 about?
NCT04329039 is a clinical study titled "Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics". Researchers are trying to determine how the length of antibiotic treatment in addition to octreotide after pancreatic surgery affects the amount of time subjects are hospitalized as well as how many subjects develop pancreatic fistulas.
What is the current status of trial NCT04329039?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 103 participants. The study started on 2020-11-17. Estimated completion is 2026-12-31.
What conditions does trial NCT04329039 study?
This clinical trial studies the following conditions: Pancreatic Diseases.
What interventions are being tested in trial NCT04329039?
The interventions under investigation include: Somatostatin analog (DRUG).
Who is sponsoring clinical trial NCT04329039?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04329039 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
UCSF PANC Cyst Registry
RECRUITING
-
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
RECRUITING
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RECRUITING
-
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
COMPLETED · Phase 3
-
Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI